Oxford Biomedica PLC
12 October 2004
Oxford BioMedica plc ('the Company')
Directors' Interest in Options over 1p Ordinary Shares
12 October 2004
The Company announced that today it has granted additional share options to
certain Directors, under the Oxford BioMedica 1996 (No.1) Share Option Scheme.
The exercise price for each of the options is 20.5 pence per share. There was no
payment in respect of the grant of these options. The new options may be
exercised between 12 October 2007 and 12 October 2011, but only if at the time
of exercise, or for at least 12 months in the three years before exercise, the
percentage increase in Oxford BioMedica's Total Shareholder Return exceeds the
percentage increase in the FTSE TechMark Mediscience index since the date of
grant of the option. The new options granted to directors are: Professor Alan
Kingsman 190,000 options, Professor Susan Kingsman 155,000 options, Peter Nolan
140,000 options and Andrew Wood 175,000 options.
Following the grant of these options, the interests of these directors in
options over 1p ordinary shares of the Company are: Professor Alan Kingsman
370,000 options, Professor Susan Kingsman 305,000 options, Peter Nolan 1,111,229
options and Andrew Wood 1,505,036 options.
Andrew Wood
Company Secretary, Oxford BioMedica plc
Tel. 01865 783000
12 October 2004
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.